A PHASE 1 STUDY TO EVALUATE THE BIOEQUIVALENCE OF ORAL TABLET AND ORALLY DISSOLVING TABLET FORMULATIONS OF RIMEGEPANT, A SMALL MOLECULE CGRP RECEPTOR ANTAGONIST

被引：0
|
作者：
Croop, R. [1 ]
Ivans, A. [1 ]
Stock, D. [1 ]
Hould, J. [1 ]
Morris, B. A. [1 ]
Stringfellow, J. [1 ]
Jensen, C. M. [1 ]
Moulin, J. -A. [2 ]
Larouche, R. [2 ]
Tanguay, M. [2 ]
Coric, V. [1 ]
Lipton, R. B. [3 ]
机构：
[1] Biohaven Pharmaceut, New Haven, CT USA
[2] Syneos Hlth, Quebec City, PQ, Canada
[3] Albert Einstein Coll Med, New York, NY USA
来源：
CEPHALALGIA | 2018年 / 38卷
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
MTIS2018-1
引用
收藏
页码：142 / 143
页数：2
相关论文
共 50 条
  • [11] Randomized, phase 1 crossover study assessing the bioequivalence of tablet and capsule formulations of dovitinib (TKI258)
    Sarantopoulos, John
    Goel, Sanjay
    Chung, Vincent
    Munster, Pamela
    Pant, Shubham
    Patel, Manish
    Infante, Jeffrey
    Tawbi, Hussein
    Becerra, Carlos
    Bruce, Justine
    Kabbinavar, Fairooz
    Kaufman, Howard
    Lockhart, A. Craig
    Tan, Eugene
    Yang, Shu
    Diallo, Mariama
    Scott, Jeffrey
    Sharma, Sunil
    CANCER RESEARCH, 2014, 74 (19)
  • [12] Bioequivalence evaluation of perampanel oral suspension and tablet formulations in healthy subjects: a Phase I, open-label, crossover study
    Laurenza, Antonio
    Hall, Nancy
    Majid, Oneeb
    Rege, Bhaskar
    NEUROLOGY, 2017, 88
  • [13] Pilot and pivotal study to evaluate the bioequivalence of two paroxetine 40 mg tablet formulations in healthy Chinese subjects
    Zhang, Shengjun
    Kan, Quancheng
    Wen, Jian Guo
    Zhao, Jie
    Sheng, Yuqiao
    Li, Yidong
    Sun, Suke
    Zhang, Feng
    Yang, Li
    Lv, Wenzhe
    Zhang, Yuanchao
    Qian, Kun
    Lin, Zhongping John
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2012, 50 (07) : 514 - 523
  • [14] Randomization bioequivalence study of oral single dose ciprofloxacin hydrochloride tablet formulations (Ciproxe and Ciprobay®) in healthy volunteers
    Alkadi, H. O.
    Noman, M. A.
    Noman, A.
    Altayeb, A.
    Zawia, N.
    Alsolwi, A.
    Alhakami, A.
    CLINICAL RESEARCH IN CARDIOLOGY, 2007, 96 (06) : 425 - 425
  • [15] Bioequivalence study of two oral tablet formulations containing saquinavir mesylate boosted with ritonavir in healthy male subjects
    Yerino, Gustavo A.
    Halabe, Emilia K.
    Zini, Elvira
    Feleder, Ethel C.
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2011, 61 (08): : 481 - 487
  • [16] Single-Dose Phase I Study To Evaluate the Pharmacokinetics of Posaconazole in New Tablet and Capsule Formulations Relative to Oral Suspension
    Krishna, Gopal
    Ma, Lei
    Martinho, Monika
    O'Mara, Edward
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (08) : 4196 - 4201
  • [17] A Phase 1 Study to Evaluate Bioequivalence Between BHV-0223 40 mg Zydis® Sublingual Formulation and Riluzole 50 mg Oral Tablet in Healthy Volunteers
    Qureshi, Irfan A.
    Coric, Vladimir
    Gentile, Kimberly
    Larouche, Richard
    Tanguay, Mario
    Berman, Robert M.
    NEUROLOGY, 2019, 92 (15)
  • [18] A PHASE 1 STUDY TO EVALUATE BIOEQUIVALENCE BETWEEN BHV-0223 40 MG ZYDIS® SUBLINGUAL FORMULATION AND RILUZOLE 50 MG ORAL TABLET IN HEALTHY VOLUNTEERS
    Qureshi, Irfan
    Coric, Vladimir
    Gentile, Kimberly
    Larouche, Richard
    Tanguay, Mario
    Berman, Robert
    MUSCLE & NERVE, 2018, 58 : S52 - S52
  • [19] Pilot study of relative bioavailability of two oral formulations of ketoprofen 25 mg in healthy subjects. A fast-dissolving lyophilized tablet as compared to immediate release tablet
    Ahmed, I. S.
    Fatahalla, F. A.
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2007, 33 (05) : 505 - 511
  • [20] Randomized phase 1 crossover study assessing the bioequivalence of capsule and tablet formulations of dovitinib (TKI258) in patients with advanced solid tumors
    Sarantopoulos, John
    Goel, Sanjay
    Chung, Vincent
    Munster, Pamela
    Pant, Shubham
    Patel, Manish R.
    Infante, Jeffrey
    Tawbi, Hussein
    Becerra, Carlos
    Bruce, Justine
    Kabbinavar, Fairooz
    Lockhart, A. Craig
    Tan, Eugene
    Yang, Shu
    Carlson, Gary
    Scott, Jeffrey W.
    Sharma, Sunil
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (05) : 921 - 927
12345